Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2026-03-26 @ 3:18 PM
Ignite Modification Date:
2026-03-26 @ 3:18 PM
NCT ID:
NCT07365267
Eligibility Criteria:
Inclusion Criteria:
* Female breast cancer patients aged 18 to 70 years.
* Histopathologically confirmed invasive breast cancer, as defined by the latest ASCO/NCCN guidelines.
* Unable to undergo breast-conserving surgery or willing to undergo total mastectomy with immediate implant-based breast reconstruction.
* ECOG performance status of 0-1.
* Voluntary participation in the study and signing of the written informed consent form.
Exclusion Criteria:
* Age \>70 years.
* Metastatic breast cancer (Stage IV) at initial diagnosis.
* Multicentric, extensive, diffuse lesions, or inflammatory breast cancer.
* Tumor involvement of the nipple-areolar complex.
* Breast cancer during pregnancy.
* History of other malignancies within the past 5 years, except for cured cervical carcinoma in situ or non-melanoma skin cancer.
* Abnormal function of vital organs such as heart, lungs, liver, or kidneys; poorly controlled diabetes, etc., rendering the patient unable to tolerate surgery.
* Patients deemed unsuitable for participation by the investigator.
Healthy Volunteers:
False
Sex:
FEMALE
Minimum Age:
18 Years
Maximum Age:
70 Years
Study:
NCT07365267
Study Brief:
Protocol Section:
NCT07365267